All News

    What To Know About Having Radiation for Metastatic Prostate Cancer

    April 1st 2025, 5:49pm

    Article

    As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical challenges.

    First Patient Dosed With Annamycin and Cytarabine in Phase 3 AML Trial

    April 1st 2025, 4:24pm

    Article

    The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the global phase 3 MIRACLE trial.

    Second-Line Tovecimig Elicits Responses in Biliary Tract Cancer

    April 1st 2025, 3:00pm

    Article

    Treatment with tovecimig, formerly known as CTX-009, elicited responses in patients with biliary tract cancer, according to COMPANION-002 study results.

    Tagrisso May Improve Survival in Advanced EGFR-Mutant NSCLC

    April 1st 2025, 1:13pm

    Article

    Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer.

    Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care

    March 31st 2025, 9:00pm

    Video

    CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.

    COCOON Trial Regimen Reduces Dermatologic Side Effects in Mutated Lung Cancer

    March 31st 2025, 8:00pm

    Article

    The COCOON trial regimen reduced dermatologic side effects in patients with EGFR-mutant non-small cell lung cancer, phase 2 trial data showed.

    First-line Rybrevant Combo Extends Survival in Advanced Lung Cancer

    March 31st 2025, 7:00pm

    Article

    First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

    The Positivity Trap of Follicular Lymphoma and Cancer

    March 31st 2025, 5:00pm

    Article

    As a lymphoma survivor, I struggle with the positivity trap — sometimes, I just want my fears validated instead of being reassured everything is fine.

    Patient With Head and Neck Cancer Dosed in Trial of APR-1051

    March 31st 2025, 4:02pm

    Article

    A patient with HPV-positive head and neck squamous cell carcinoma was dosed in a phase 1 clinical trial evaluating APR-1051.

    Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial

    March 31st 2025, 3:29pm

    Article

    The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ovarian cancer.